Tarsus Pharmaceuticals, Inc.

TARS · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $2.7B · 370 employees
110
SEC Filings
$68.6
Close 2026-11-06
370
Employees

Business Summary

Tarsus Pharmaceuticals is a commercial stage biopharmaceutical company focused on eye care therapeutics. It launched XDEMVY (lotilaner ophthalmic solution) 0.25% in August 2023, the first and only FDA-approved treatment for Demodex blepharitis, generating over $646 million in net product sales launch-to-date. The company's pipeline includes TP-04, an investigational gel formulation of lotilaner for ocular rosacea, and TP-05, an investigational oral tablet for Lyme disease prophylaxis and community malaria reduction. Tarsus has completed seven clinical trials for XDEMVY and is advancing lotilaner-based products across eye care and infectious disease prevention.

Latest Stock Quote

TARS 2026-11-06 $68.6 O:$67.78 H:$69.035 L:$66.53 Vol:1.1M VWAP:$68.2994
origin leaf: null

Next Earnings

expected 2026-11-05

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-232025-12-310001819790-26-000019EDGAR107K words
2025-02-252024-12-310001819790-25-000011EDGAR109K words
2024-02-272023-12-310001819790-24-000018EDGAR104K words
2023-03-172022-12-310001819790-23-000007EDGAR98K words
2022-03-142021-12-310001819790-22-000010EDGAR97K words
2021-03-312020-12-310001819790-21-000010EDGAR101K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-032026-09-300001819790-26-000076EDGAR85K words
2026-08-062026-06-300001819790-26-000064EDGAR79K words
2025-11-042025-09-300001819790-25-000121EDGAR75K words
2025-08-062025-06-300001819790-25-000108EDGAR75K words
2025-05-012025-03-310001819790-25-000078EDGAR73K words
2024-11-132024-09-300001819790-24-000129EDGAR77K words
2024-08-082024-06-300001819790-24-000111EDGAR76K words
2024-05-082024-03-310001819790-24-000063EDGAR74K words
2023-11-092023-09-300001819790-23-000080EDGAR31K words
2023-08-102023-06-300001819790-23-000071EDGAR29K words
2023-05-092023-03-310001819790-23-000030EDGAR25K words
2022-11-092022-09-300001819790-22-000042EDGAR25K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-030001819790-26-000074EDGAR4K words
2026-09-100001819790-26-000066EDGAR1K words
2026-08-060001819790-26-000063EDGAR4K words
2026-08-060001819790-26-000062EDGAR22K words
2026-08-060001819790-26-000060EDGAR2K words
2026-07-130001819790-26-000048EDGAR0K words
2026-02-230001819790-26-000017EDGAR4K words
2026-02-180001819790-26-000005EDGAR1K words
2026-01-120001819790-26-000002EDGAR1K words
2025-11-040001819790-25-000120EDGAR4K words

110 total filings indexed. 82 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

eye-care demodex-blepharitis-treatment ocular-rosacea lyme-disease-prophylaxis infectious-disease-prevention meibomian-gland-disease

Company Identity

CIK0001819790
TickerTARS
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.tarsusrx.com
Listed2020-10-16

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: ade5b5a46ae7528221fc38fba276652a0b12083645deec56dca4961a757aad15
parent: 3862995ebbea1f378eb62957c302f52a2966fdc61bd5714d992f42cc5ca59ac5
content hash: 6628ae994a1e0578a0eeb86edd27c160cda4a5c433874e289ebc2b54e5ee2169
signed: 2026-11-16T19:05:03.156Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up TARS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on TARS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/TARS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.